Herein, we sought to elucidate the impact of low-dose IL-2-mediated transformation and expansion of Tregs in the peripheral blood and lymphoid tissues of mice, and to evaluate the neuroprotective capabilities of Tregs generated by this pharmacological intervention in a PD animal model. Here, IL2 is linked to Parkinson disease.